Great Basin Scientific (GBSN) Reports Q4 Loss Per Share of $5.15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
- Moderna stock rises on latest cancer vaccine data publication
Great Basin Reports Fourth Quarter 2015 and Full Year 2015 Results
March 1, 2016 4:00 PM ESTReports Fourth Quarter Revenue Growth of 37.4 Percent
SALT LAKE CITY--(BUSINESS WIRE)-- Great Basin Scientific, Inc. (NASDAQ: GBSN), a molecular diagnostic testing company, today reported financial results for the fourth quarter and the full year ended December 31, 2015. For the fourth quarter of 2015, revenue was $611,870, increasing 37.4% over the fourth quarter of 2014. For the year ended December 31, 2015 revenue was $2,142,040, an increase of 33.4% compared to the 12 months ended December 31, 2014.
Fourth Quarter 2015 Financial and Business Highlights
186 revenue-generating customers as of December 31, 2015, increasing to 201 as of January 31,... More


